HeartFlow, Inc.

About HeartFlow, Inc.

HeartFlow, Inc. is a pioneering healthcare technology company that focuses on transforming cardiovascular care through advanced imaging and analytics. Founded with the vision of improving patient outcomes, HeartFlow leverages cutting-edge technology to provide non-invasive solutions for coronary artery disease (CAD). The company’s flagship product, the HeartFlow Analysis, uses artificial intelligence to create a 3D model of a patient’s coronary arteries, allowing physicians to assess the severity of blockages and make informed treatment decisions.

With a commitment to innovation, HeartFlow aims to enhance the diagnostic process and streamline patient management. The company collaborates with leading healthcare providers and institutions to integrate its technology into clinical practice, ensuring that patients receive timely and accurate diagnoses. HeartFlow’s solutions not only improve patient care but also reduce healthcare costs by minimizing unnecessary procedures.

HeartFlow is dedicated to advancing research in cardiovascular health, contributing to numerous studies that validate the effectiveness of its technology. The company’s mission is to empower healthcare professionals with the tools they need to deliver personalized care, ultimately leading to better health outcomes for patients worldwide.

As a leader in the field of cardiac imaging, HeartFlow continues to expand its reach and impact, striving to be at the forefront of medical innovation. The company is headquartered in the UK and operates globally, reflecting its commitment to addressing the challenges of cardiovascular disease on an international scale.